These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 31806515)
1. Management of morbidity associated with pancreatic resection during cytoreductive surgery for epithelial ovarian cancer: A systematic review. Di Donato V; Bardhi E; Tramontano L; Capomacchia FM; Palaia I; Perniola G; Plotti F; Angioli R; Giancotti A; Muzii L; Panici PB Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):694-702. PubMed ID: 31806515 [TBL] [Abstract][Full Text] [Related]
2. Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer. Xiang L; Tu Y; He T; Shen X; Li Z; Wu X; Yang H J Gynecol Oncol; 2016 Nov; 27(6):e62. PubMed ID: 27550408 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic Resection as Part of Cytoreductive Surgery in Advanced-stage and Recurrent Epithelial Ovarian Cancer--A Single-center Experience. Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I Anticancer Res; 2015 Jul; 35(7):4125-9. PubMed ID: 26124365 [TBL] [Abstract][Full Text] [Related]
4. Post-operative pancreatic fistula following splenectomy with or without distal pancreatectomy at cytoreductive surgery in advanced ovarian cancer. Bizzarri N; Korompelis P; Ghirardi V; O'Donnell RL; Rundle S; Naik R Int J Gynecol Cancer; 2020 Jul; 30(7):1043-1051. PubMed ID: 32546641 [TBL] [Abstract][Full Text] [Related]
5. Predictors of postoperative pancreatic fistula after splenectomy with or without distal pancreatectomy performed as a component of cytoreductive surgery for advanced ovarian cancer. Nishikimi K; Tate S; Matsuoka A; Otsuka S; Shozu M J Gynecol Oncol; 2022 May; 33(3):e30. PubMed ID: 35128860 [TBL] [Abstract][Full Text] [Related]
6. [Clinical observation of partial pancreatectomy as part of primary cytoreductive surgery in advanced epithelial ovarian cancer]. Xiang LB; Tu YX; He TC; Pei X; Shen XX; Yang WT; Wu XH; Yang HJ Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):361-5. PubMed ID: 27256444 [TBL] [Abstract][Full Text] [Related]
7. Cytoreductive surgery including distal pancreatectomy with splenectomy in advanced stage ovarian cancer: Two centers analysis. Erturk A; Kuru O; Akgor U; Boyraz G; Cakir C; Turan T; Ozgul N; Salman C; Yuce K Taiwan J Obstet Gynecol; 2020 Nov; 59(6):862-864. PubMed ID: 33218402 [TBL] [Abstract][Full Text] [Related]
8. Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upper abdominal surgery. Benedetti Panici P; Di Donato V; Fischetti M; Casorelli A; Perniola G; Musella A; Marchetti C; Palaia I; Berloco P; Muzii L Gynecol Oncol; 2015 Jun; 137(3):406-11. PubMed ID: 25824857 [TBL] [Abstract][Full Text] [Related]
9. Splenectomy as Part of Cytoreductive Surgery in Recurrent Epithelial Ovarian Cancer. Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I Anticancer Res; 2015 Sep; 35(9):5097-101. PubMed ID: 26254413 [TBL] [Abstract][Full Text] [Related]
10. Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population-based cohort study. Said SA; van der Aa MA; Veldmate G; de Hullu JA; van Altena AM Acta Obstet Gynecol Scand; 2022 Jan; 101(1):56-67. PubMed ID: 34719790 [TBL] [Abstract][Full Text] [Related]
11. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome. Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382 [TBL] [Abstract][Full Text] [Related]
12. The feasibility and morbidity of distal pancreatectomy in extensive cytoreductive surgery for advanced epithelial ovarian cancer. Yildirim Y; Sanci M Arch Gynecol Obstet; 2005 Jun; 272(1):31-4. PubMed ID: 15480722 [TBL] [Abstract][Full Text] [Related]
13. Splenectomy at the time of primary or interval cytoreductive surgery for epithelial ovarian carcinoma: A review of outcomes. Rush SK; Lees BF; Huang DS; Peterson MF; Al-Niaimi A Gynecol Oncol; 2022 Nov; 167(2):283-288. PubMed ID: 36114028 [TBL] [Abstract][Full Text] [Related]
14. National trends in bowel and upper abdominal procedures in ovarian cancer surgery. Dottino JA; He W; Sun CC; Zhao H; Fu S; Rauh-Hain JA; Suidan RS; Lu KH; Giordano SH; Meyer LA Int J Gynecol Cancer; 2020 Aug; 30(8):1195-1202. PubMed ID: 32616627 [TBL] [Abstract][Full Text] [Related]
15. When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer. Brown J; Drury L; Crane EK; Anderson WE; Tait DL; Higgins RV; Naumann RW J Minim Invasive Gynecol; 2019; 26(5):902-909. PubMed ID: 30240899 [TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes of diaphragmatic resection during cytoreductive surgery for advanced gynecological ovarian neoplasia: A randomized single center clinical trial - DRAGON. Cianci S; Fedele C; Vizzielli G; Pasciuto T; Gueli Alletti S; Cosentino F; Chiantera V; Fagotti A; Scambia G Gynecol Oncol; 2022 Feb; 164(2):271-277. PubMed ID: 34844774 [TBL] [Abstract][Full Text] [Related]
17. Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution. Goh BK; Tan YM; Chung YF; Cheow PC; Ong HS; Chan WH; Chow PK; Soo KC; Wong WK; Ooi LL Arch Surg; 2008 Oct; 143(10):956-65. PubMed ID: 18936374 [TBL] [Abstract][Full Text] [Related]
18. Complications after pancreatic resection: diagnosis, prevention and management. Lermite E; Sommacale D; Piardi T; Arnaud JP; Sauvanet A; Dejong CH; Pessaux P Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):230-9. PubMed ID: 23415988 [TBL] [Abstract][Full Text] [Related]
19. Is the Combination of Distal Pancreatectomy and Cytoreductive Surgery With HIPEC Reasonable?: Results of an International Multicenter Study. Schwarz L; Votanopoulos K; Morris D; Yonemura Y; Deraco M; Piso P; Moran B; Levine EA; Tuech JJ Ann Surg; 2016 Feb; 263(2):369-75. PubMed ID: 25915913 [TBL] [Abstract][Full Text] [Related]
20. Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy. Abitbol J; Gotlieb W; Zeng Z; Ramanakumar A; Kessous R; Kogan L; Pare-Miron V; Rombaldi M; Salvador S; Kucukyazici B; Brin S; How J; Lau S Int J Gynecol Cancer; 2019 Nov; 29(9):1341-1347. PubMed ID: 31601648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]